药物性体重增加与超重和肥胖儿童的先进治疗方法：肥胖医学协会（OMA）2022年临床实践声明

Medication-induced weight gain and advanced therapies for the child with overweight and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement 2022.

作者信息

Cuda Suzanne, Censani Marisa, Kharofa Roohi, O'Hara Valerie, Conroy Rushika, Williams Dominique R, Paisley Jennifer, Browne Allen F, Karjoo Sara, Browne Nancy T

机构信息

Alamo City Healthy Kids and Families, 1919 Oakwell Farms Parkway, Ste 145, San Antonio, TX, 78218, USA.

Division of Pediatric Endocrinology, Department of Pediatrics, New York Presbyterian Hospital, Weill Cornell Medicine, 525 East 68th Street, Box 103, New York, NY, 10021, USA.

出版信息

Obes Pillars. 2022 Dec 5;4:100048. doi: 10.1016/j.obpill.2022.100048. eCollection 2022 Dec.

BACKGROUND

This Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) details medication-induced weight gain and advanced therapies for the child with overweight or obesity.

METHODS

The scientific information and clinical guidance in this CPS are based on scientific evidence, supported by the medical literature, and derived from the clinical perspectives of the authors.

RESULTS

This OMA Clinical Practice Statement addresses medication-induced weight gain and advanced therapies for the child with overweight or obesity.

CONCLUSIONS

This OMA Clinical Practice Statement on medication induced-weight gain and advanced therapies for the child with overweight or obesity is an overview of current recommendations. These recommendations provide a roadmap to the improvement of the health of children and adolescents with obesity, especially those with metabolic, physiological, and psychological complications. This CPS also addresses treatment recommendations. This section is designed to help the provider with clinical decision making.